Trial Profile
A 26-week Open Label, Randomised, 2-armed, Parallel Group, Multi-centre Trial Investigating Efficacy and Safety of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn in Combination With the Maximum Tolerated Dose of Metformin and Diet/Exercise on Glycaemic Control in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on the Maximum Tolerated Dose of Metformin ± Other Oral Antidiabetic Drug(s) ± Basal Insulin
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin suspension isophane; Metformin
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms iDEAt2
- Sponsors Novo Nordisk
- 01 Oct 2018 Primary endpoint has not been met. (Change in HbA1c (Glycosylated Haemoglobin)) as per results published in the European Journal of Pediatrics
- 01 Oct 2018 Results published in the European Journal of Pediatrics
- 02 Aug 2017 Status changed from completed to discontinued.